Cis Eligible Muscle Invasive Bladder Cancer clinical trials

Explore recruiting cis eligible muscle invasive bladder cancer clinical trials.

Also recruiting in Europe

Cis Eligible Muscle Invasive Bladder Cancer trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Phase 3, Randomized, Double-blind Study to Evaluate Perioperative Pembrolizumab (MK-3475) + Neoadjuvant Chemotherapy versus Perioperative Placebo + Neoadjuvant Chemotherapy in Cisplatin-eligible Participants with Muscle-invasive Bladder Cancer (KEYNOTE-866)

Hungary, Belgium, Germany, Sweden, Spain, France +4 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

Cis Eligible Muscle Invasive Bladder Cancer trials by city

Cis Eligible Muscle Invasive Bladder Cancer in Toronto Cis Eligible Muscle Invasive Bladder Cancer in Vancouver Cis Eligible Muscle Invasive Bladder Cancer in Montreal Cis Eligible Muscle Invasive Bladder Cancer in Calgary Cis Eligible Muscle Invasive Bladder Cancer in Edmonton Cis Eligible Muscle Invasive Bladder Cancer in Ottawa Cis Eligible Muscle Invasive Bladder Cancer in Winnipeg Cis Eligible Muscle Invasive Bladder Cancer in Quebec City Cis Eligible Muscle Invasive Bladder Cancer in Hamilton Cis Eligible Muscle Invasive Bladder Cancer in Kitchener Cis Eligible Muscle Invasive Bladder Cancer in London Cis Eligible Muscle Invasive Bladder Cancer in Halifax Cis Eligible Muscle Invasive Bladder Cancer in New York Cis Eligible Muscle Invasive Bladder Cancer in Los Angeles Cis Eligible Muscle Invasive Bladder Cancer in Chicago Cis Eligible Muscle Invasive Bladder Cancer in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease